Surgical Process Institute to be acquired by J&J's German device unit | Spinal Singularity gets $3.1M boost | Funding round pulls in around $2.1M for AventaMed
October 20, 2017
ADVAMED SmartBrief
News for medical technology professionals
Top Story
Surgical Process Institute to be acquired by J&J's German device unit
An agreement has been reached by Johnson & Johnson's German device unit, Johnson & Johnson GmbH, to buy Surgical Process Institute, a German software firm that specializes in surgical workflow standardization and digitization in the surgical theater. The acquisition, for which terms were not disclosed, is expected to be completed this quarter.
Seeking Alpha (free registration) (10/19) 
LinkedIn Twitter Facebook Google+ Email
Modernize Your Medical Device Business with the #1 Cloud ERP
The challenges facing medical tech manufacturers are constantly evolving. Legacy on-premise systems cannot keep pace - for future success businesses need a flexible, business-ready solution. Try NetSuite for Medical Device companies and discover your competitive edge.
Business & Market Trends
Spinal Singularity gets $3.1M boost
A round of seed financing pulled in $3.1 million for San Clemente, Calif.-based Spinal Singularity. The money will be used for clinical validation of the company's Connected Catheter, which is designed to last 29 days, reducing urinary tract infections and replacing disposable intermittent catheters in men with chronic lower urinary tract dysfunction.
MassDevice (Boston) (10/19) 
LinkedIn Twitter Facebook Google+ Email
Funding round pulls in around $2.1M for AventaMed
A round of financing brought in about $2.1 million for Irish medtech company AventaMed, a spin-out from the Cork Institute of Technology's Medic research center, that makes the Solo Tympanostomy Tube Device for simplifying insertion of plastic ear tubes in pediatric patients with ear infections and hearing loss. The proceeds will be used to help the company secure approval from the FDA and enter the US market.
The Irish Times (Dublin) (10/19) 
LinkedIn Twitter Facebook Google+ Email
Quest Diagnostics enters deal to acquire Cleveland HeartLab
Quest Diagnostics agreed to buy Cleveland Clinic spinoff Cleveland HeartLab, a company that offers biomarker tests for predicting cardiovascular diseases, under an equity deal that is expected to close in the fourth quarter. Quest will also partner with the Cleveland Clinic for diagnostic services and create a national center of excellence in cardiometabolic disorders at Cleveland HeartLab.
The Plain Dealer (Cleveland) (10/19) 
LinkedIn Twitter Facebook Google+ Email
Insulet enters promotion partnership with Dexcom
A partnership was reached by Insulet and Dexcom to provide users of the Animas insulin pump with a Welcome Program that includes a free Omnipod tubeless insulin delivery system, built-in blood glucose meter and 30 days of supplies, as well as a $200 gift card for the purchase of Dexcom's G5 mobile continuous glucose monitor. The partnership comes after Johnson & Johnson announced its exit from the insulin pump business.
Drug Delivery Business News (10/19) 
LinkedIn Twitter Facebook Google+ Email
Post-Hurricane Maria slowdown in device operations could lead to shortages
A prolonged slowdown in Puerto Rican medical device manufacturing operations after Hurricane Maria could result in shortages in trauma-based devices, valves, surgical sutures and catheters, among other products, said Greg Crist, a spokesman for AdvaMed. Twenty-three of AdvaMed's members in Puerto Rico are relying on generator power, and "if the situation does not change in the next three to seven weeks, you're going to see drawdowns and eventual shortages," Crist said.
Gastroenterology & Endoscopy News online (10/19) 
LinkedIn Twitter Facebook Google+ Email
7 keys: Put real-world evidence into action
Life sciences organizations need to know how their therapies work in the real world once clinical trials end. And these seven key components to standardizing real-world data and analytics platforms are how they get started. Read the paper, Institutionalizing Real World Evidence.
Science & Health
France OKs trial of Pixium Vision's next-gen subretinal implant
France's regulatory agency granted Pixium Vision approval to conduct a five-patient feasibility clinical study of the Prima system, a next-generation subretinal wireless implant system intended for the treatment of retinal dystrophies with a focus on advanced atrophic dry age-related macular degeneration. The study will assess the system's tolerance, as well as evoked central visual perception, among patients who lost their sight because of dry AMD, with evaluations at six months and 36 months.
MassDevice (Boston) (10/19) 
LinkedIn Twitter Facebook Google+ Email
Emerging Technologies
Varian announces EU launch of radiotherapy cancer treatment system
The Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system was launched by Varian Medical in the European Union, with the first procedure using the product recorded in Belgium. The system comes with enhancements that improve patient comfort and streamline workflow of the operator, reducing the steps from start to treatment from 30 in legacy machines to nine in the Halycyon system.
MassDevice (Boston) (10/19) 
LinkedIn Twitter Facebook Google+ Email
3D-printed XLIF titanium implant debuted by NuVasive
Modulus XLIF, a 3D-printed porous titanium implant, was launched by NuVasive for use in extreme lateral interbody fusion procedures. The implant is made with an additive manufacturing technology that allows for reduced stress shielding by creating an architecture that imitates the porosity and stiffness of the natural bone.
Becker's Spine Review (10/19) 
LinkedIn Twitter Facebook Google+ Email
Government & Regulatory
EU approves Implanet's Jazz Platform
European regulators gave Implanet CE mark approval for Jazz Passer, a system intended for use in posterior fixation during spine surgery for treating degenerative scoliosis deformities and trauma pathologies. The system comes with new instruments, including a variation of the company's Jazz Band braid and is compatible with the whole Jazz Platform.
Becker's Spine Review (10/19) 
LinkedIn Twitter Facebook Google+ Email
AdvaMed Events and Education
MedTech Coverage, Coding, & Reimbursement 201 Workshop
Oct. 25-26, 2017 | San Diego, Calif.
This next-level reimbursement workshop was created with the more advanced professional in mind. You'll walk away from this workshop with more insight into the complex and critical nature of coverage issues and policy. Learn more.
LinkedIn Twitter Facebook Google+ Email
Start saving with the AdvaMed Purchasing Group
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.
LinkedIn Twitter Facebook Google+ Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
powered by
Vice President, Clinical Research & Regulatory Affairs
Senior Manager, Regulatory Affairs - Transcatheter Mitral and Tricuspid Therapies
Director, Regulatory Affairs - Transcatheter Mitral & Tricuspid Therapies
I like work; it fascinates me. I can sit and look at it for hours.
Jerome K. Jerome,
writer and humorist
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Jobs Contact  -
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information